Article Details

Insilico Medicine scores $255M venture round to move AI-designed drugs into human clinical trials

Retrieved on: 2021-06-22 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

Insilico Medicine scores $255M venture round to move AI-designed drugs into human clinical trials. View article details on hiswai:

Excerpt

The advent of artificial intelligence holds the promise to reset the industry's expectations of how long it should take to develop a new drug from scratch.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo